ONCORUS INC has a total of 53 patent applications. It increased the IP activity by 14.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PALLI SUBBA REDDY, GX BIOSYSTEMS AS and BEIJING BIOHEALTHCARE BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 4 | |
#5 | Brazil | 4 | |
#6 | Canada | 4 | |
#7 | China | 4 | |
#8 | Republic of Korea | 4 | |
#9 | Singapore | 4 | |
#10 | Israel | 3 | |
#11 | Mexico | 2 | |
#12 | Taiwan | 2 | |
#13 | Argentina | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Peptides | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Finer Mitchell H | 33 |
#2 | Lerner Lorena | 20 |
#3 | Kennedy Edward | 16 |
#4 | Evnin Luke | 13 |
#5 | Greenberg Kenneth P | 11 |
#6 | Quéva Christophe | 6 |
#7 | Mitchell H Finer | 4 |
#8 | Queva Christophe | 4 |
#9 | Kennedy Edward M | 4 |
#10 | Lorena Lerner | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021072310A1 | Dual viruses and dual oncolytic viruses and methods of treatment | |
TW202043480A | Encapsulated rna polynucleotides and methods of use | |
WO2020102285A1 | Encapsulated polynucleotides and methods of use | |
US2021085735A1 | Oncolytic viral delivery of therapeutic polypeptides | |
KR20200042904A | Oncolytic virus vectors and uses thereof | |
AU2018301701A1 | Encapsulated polynucleotides and methods of use | |
EP3478321A1 | Pseudotyped oncolytic viral delivery of therapeutic polypeptides | |
AU2017212713A1 | Oncolytic viral vectors and uses thereof |